HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,538 | +34.5% | 91,784 | +51.5% | 0.00% | – |
| Q2 2023 | $70,283 | -56.1% | 60,589 | -42.8% | 0.00% | – |
| Q1 2023 | $160,070 | -44.6% | 106,007 | -8.3% | 0.00% | – |
| Q4 2022 | $288,990 | -87.9% | 115,596 | -79.6% | 0.00% | – |
| Q3 2022 | $2,392,000 | +17.9% | 566,856 | -22.0% | 0.00% | – |
| Q2 2022 | $2,028,000 | -77.9% | 726,937 | -54.8% | 0.00% | -100.0% |
| Q1 2022 | $9,191,000 | +191.6% | 1,606,844 | +365.4% | 0.00% | – |
| Q4 2021 | $3,152,000 | +177.0% | 345,244 | +224.1% | 0.00% | – |
| Q3 2021 | $1,138,000 | -40.4% | 106,536 | -13.4% | 0.00% | – |
| Q2 2021 | $1,910,000 | -59.4% | 123,069 | -57.5% | 0.00% | -100.0% |
| Q1 2021 | $4,699,000 | +10.1% | 289,905 | +43.8% | 0.00% | 0.0% |
| Q4 2020 | $4,269,000 | +27.4% | 201,666 | -10.8% | 0.00% | – |
| Q3 2020 | $3,352,000 | +6.8% | 226,190 | +5.9% | 0.00% | – |
| Q2 2020 | $3,140,000 | -26.0% | 213,509 | -41.0% | 0.00% | -100.0% |
| Q1 2020 | $4,246,000 | -47.1% | 361,657 | +5.9% | 0.00% | 0.0% |
| Q4 2019 | $8,028,000 | +64.1% | 341,646 | +29.2% | 0.00% | 0.0% |
| Q3 2019 | $4,891,000 | -28.9% | 264,343 | -28.6% | 0.00% | 0.0% |
| Q2 2019 | $6,882,000 | -37.3% | 370,172 | -17.6% | 0.00% | -50.0% |
| Q1 2019 | $10,977,000 | +54.3% | 449,134 | +63.9% | 0.00% | +100.0% |
| Q4 2018 | $7,112,000 | -26.7% | 274,095 | -10.5% | 0.00% | 0.0% |
| Q3 2018 | $9,698,000 | -41.5% | 306,419 | -28.2% | 0.00% | -66.7% |
| Q2 2018 | $16,581,000 | +137.6% | 426,780 | +68.7% | 0.00% | +200.0% |
| Q1 2018 | $6,980,000 | +273.7% | 252,924 | +145.0% | 0.00% | – |
| Q4 2017 | $1,868,000 | -7.2% | 103,214 | -17.3% | 0.00% | – |
| Q3 2017 | $2,014,000 | -13.7% | 124,735 | -26.0% | 0.00% | – |
| Q2 2017 | $2,334,000 | +186.4% | 168,465 | +210.1% | 0.00% | – |
| Q1 2017 | $815,000 | +20.7% | 54,329 | +5.5% | 0.00% | – |
| Q4 2016 | $675,000 | -12.2% | 51,495 | +15.3% | 0.00% | – |
| Q3 2016 | $769,000 | +3.6% | 44,647 | +8.5% | 0.00% | – |
| Q2 2016 | $742,000 | -56.6% | 41,134 | -54.3% | 0.00% | – |
| Q1 2016 | $1,709,000 | +64.5% | 89,999 | +131.2% | 0.00% | – |
| Q4 2015 | $1,039,000 | +385.5% | 38,929 | +345.5% | 0.00% | – |
| Q3 2015 | $214,000 | -58.9% | 8,739 | -47.7% | 0.00% | – |
| Q2 2015 | $521,000 | +52000.0% | 16,708 | +24114.5% | 0.00% | – |
| Q1 2015 | $1,000 | -94.4% | 69 | -96.2% | 0.00% | – |
| Q4 2014 | $18,000 | -58.1% | 1,800 | -65.1% | 0.00% | – |
| Q3 2014 | $43,000 | -44.9% | 5,160 | -19.0% | 0.00% | – |
| Q2 2014 | $78,000 | – | 6,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |